The Neurology Market: A Glance (video)
The plethora of recent reports of new genes and pathways linked to neurological diseases shows that the underlying causes of these diseases are far from certain.
The plethora of recent reports of new genes and pathways linked to neurological diseases shows that the underlying causes of these diseases are far from certain.
OneMedPlace is pleased to announce panelists at the 4th annual OneMedForum business development and investment conference January 11-13th in San Francisco.
NeuroPace, a company focused on implantable devices for the treatment of brain disorders, announced Thursday that it has filed for Pre-Market Approval with the U.S. Food and Drug Administration for its investigational device for epilepsy patients.
Copyright © 2024 | WordPress Theme by MH Themes